Addex Pharmaceuticals Ltd/ CH0029850754 /
2022-02-03 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.9900USD | - | 100 Turnover: - |
-Bid Size: - | -Ask Size: - | 12.93 mill.USD | - | - |
Assets
2011 IFRS in mill. CHF |
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 4 | 2.1000 | .2000 | 0.0000 | 0.0000 | ||||||
Intangible Assets | 0.0000 | .1000 | .1000 | 0.0000 | 0.0000 | ||||||
Long-Term Investments | 0.0000 | 2.5000 | 1.7000 | 1.8000 | .1000 | ||||||
Fixed Assets | 5.5000 | 4.7000 | 2 | 1.9000 | .1000 | ||||||
Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 36.1000 | 15.3000 | 2.9000 | 2 | 2.6000 | ||||||
Current Assets | 38.1000 | 17 | 3.9000 | 2.1000 | 2.8000 | ||||||
Total Assets | 43.6000 | 21.7000 | 5.9000 | 4 | 2.9000 |
Liabilities
2011 IFRS in mill. CHF |
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 8.5000 | 4.6000 | 2.4000 | 1.5000 | 1 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 9.8000 | 5.4000 | 2.9000 | 1.7000 | 1.2000 | ||||||
Share Capital | 7.7000 | 8.6000 | 9.8000 | 10 | 11 | ||||||
Total Equity | 33.8000 | 16.3000 | 3 | 2.3000 | 1.6000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 43.6000 | 21.7000 | 5.9000 | 4 | 2.9000 |
Income Statement
2011 IFRS in mill. CHF |
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.7000 | .1000 | .1000 | .7000 | .8000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -31 | -27 | -14.5000 | -1.8000 | -3.9000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -31.1000 | -27 | -14.5000 | -1.8000 | -4.2000 | ||||||
Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -31.1000 | -27 | -14.5000 | -1.8000 | -4.2000 |
Per Share
Cash Flow
2011 IFRS in mill. CHF |
2012 IFRS in mill. CHF |
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -26.6000 | -29.5000 | -15.8000 | -1.8000 | -2.6000 | ||||||
Cash Flow from Investing Activities | -.8000 | -.2000 | .3000 | .4000 | .4000 | ||||||
Cash Flow from Financing | -.2000 | 8.9000 | 3.2000 | .5000 | 2.9000 | ||||||
Decrease / Increase in Cash | -27.5000 | -20.8000 | -12.3000 | -1 | .7000 | ||||||
Employees | 81 | 56 | 5 | 5 | 8 |